Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
Sales | 7,677,000 | 8,170,000 | 7,150,000 | 7,300,000 | 6,966,000 |
Cost of Goods | 1,502,000 | N/A | N/A | 1,668,000 | 1,486,000 |
Gross Profit | 6,175,000 | 8,170,000 | 7,150,000 | 5,605,000 | 5,480,000 |
Operating Expenses | 4,039,000 | 0 | 0 | 3,891,000 | 3,448,000 |
Operating Income | 2,136,000 | 8,170,000 | 7,150,000 | 1,741,000 | 2,032,000 |
Other Income | 7,000 | 0 | 0 | 250,000 | 235,000 |
Pre-tax Income | 2,143,000 | 8,170,000 | 7,150,000 | 1,991,000 | 2,267,000 |
Income Tax | 638,000 | N/A | N/A | 554,000 | 703,000 |
Net Income Continuous | 1,505,000 | 1,280,000 | 1,340,000 | 1,400,000 | 1,564,000 |
Net Income | $1,505,000 | $1,280,000 | $1,340,000 | $1,400,000 | $1,564,000 |
EPS Basic Total Ops | 0.52 | 0.43 | 0.46 | 0.48 | 0.51 |
EPS Basic Continuous Ops | 0.52 | 0.43 | 0.46 | 0.48 | 0.51 |
EPS Diluted Total Ops | 0.52 | 0.43 | 0.46 | 0.48 | 0.51 |
EPS Diluted Continuous Ops | 0.52 | 0.43 | 0.46 | 0.48 | 0.51 |
EBITDA(a) | $2,838,000 | $8,170,000 | $7,150,000 | $2,110,000 | $2,402,000 |